1,189 Followers on Owler

Actelion

Actelion is a bio-technology firm that discovers, develops and commercializes drugs for unmet medical needs. Read more

CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Founded:

1997

Status:

ACTELION TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Gilead is seen as one of Actelion's biggest rivals. Gilead was founded in 1987 in Foster City, California. Like Actelion, Gilead also operates in the Pharmaceuticals sector. Gilead generates $23.2B more revenue than Actelion.

Genentech is one of Actelion's top competitors. Genentech was founded in 1976, and its headquarters is in South San Francisco, California. Like Actelion, Genentech also operates in the Pharmaceuticals space. Genentech has 11,079 more employees than Actelion.

Amgen is one of Actelion's top rivals. Amgen was founded in 1980, and is headquartered in Thousand Oaks, California. Like Actelion, Amgen also works within the Pharmaceuticals sector. Amgen generates $22.8B more revenue vs. Actelion.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 2,421 a good estimate for Actelion's Employee count?

Actelion Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Axovan AG

Sep 2003

Source »
$45.2M
-

These are all the companies that Actelion has acquired. Actelion's latest acquisition was Axovan AG in Sep 2003.

Actelion Funding History

No recent funding data found related to Actelion

Actelion Investments

No recent investments found related to Actelion

These are all the companies that Actelion has invested in. Actelion's latest investment was Axovan AG in Sep 2003.

Actelion News

August 29, 2020MarketScreener

TRITON Phase 3b Study Results Presented at the European Society of Cardiology Congress

(marketscreener.com) While the primary endpoint was not met, exploratory analysis suggests a signal o... See more »
June 18, 2020Zolmax News

Actelion (OTCMKTS:ALIOF) Getting Very Negative Media Coverage, Report Finds

News stories about Actelion (OTCMKTS:ALIOF) have been trending very negative on Thursday, according t... See more »
May 18, 2020Zolmax News

Actelion (OTCMKTS:ALIOF) vs. Aphria (OTCMKTS:APHA)

Actelion (OTCMKTS:ALIOF) and Aphria (NYSE:APHA) are both medical companies, but which is the better b... See more »
May 1, 2020The Pharma Letter

BRIEF-Actelion's Opsumit improves RV function in PAH trial

Switzerland-based Actelion has presented new trial results on the effects of Opsumit (macitentan) on.... See more »
January 26, 2020BioPortfolio

Actelion Ltd Strategy SWOT and Corporate Finance Report Published by Marketline Prices from USD $149

Actelion Ltd Strategy SWOT and Corporate Finance ReportSummaryActelion Ltd Strategy SWOT and Corporat... See more »
November 13, 2019The Pharma Letter

Actelion pulls supplemental indication applications for Opsumit

Actelion Pharmaceuticals has decided to voluntarily withdraw the European and other health authority.... See more »
July 26, 2019FinanzNachrichten

Janssen's Late-stage Study On Relapsing Multiple Sclerosis Meets Primary Goal

NEW BRUNSWICK (dpa-AFX) - Idorsia Ltd said that the Janssen Pharmaceutical Companies of Johnson & Joh... See more »

Actelion Press Releases

September 18, 2018Social Media Portal

Actelion's Pieter De Muynck on the forthcoming Marketing & CX Pharm

Learn what to expect from Actelion & Marketing and CX in the Pharmaceutical Industry Conference with ... See more »
February 6, 2018GlobeNewswire

Idorsia announces financial results for 2017 - company off to a great start - 4 compounds to enter Phase 3 development

Allschwil, Switzerland - 06 February 2018 - Idorsia Ltd (SIX: IDIA) today announced its financial res... See more »
February 7, 2017Business Wire

Gaucher Disease - Pipeline Review, H2 2016 - Therapeutics Assessment by Drug Target, MoA, RoA & Molecule Type - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Gaucher Disease - Pi... See more »
January 26, 2017GlobalNewswire

Press Release German

January 26, 2017GlobeNewswire

Press Release German

December 27, 2016PressReleasePing

Actelion Ltd - Strategy, SWOT and Corporate Finance Report

Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data... See more »

Social Media

Actelion Headquarters

Gewerbestrasse 16

Allschwil, Basel-Country4123

41-61-565-6565

Driving Directions »

Trending Companies

Actelion Summary

ABOUT

Overview

Actelion is a bio-technology firm that discovers, develops and commercializes drugs for unmet medical needs. Actelion was founded in 1997. Actelion's headquarters is located in Allschwil, Basel-Country, CH 4123. Actelion's latest acquisition was Axova...

Frequently Asked Questions about Actelion

  1. When was Actelion founded?

    Actelion was founded in 1997
  2. How much revenue does Actelion generate?

    Actelion generates $2.4B in revenue
  3. How much funding does Actelion have?

    Actelion has historically raised $0 in funding
  4. Where is Actelion's headquarters?

    Actelion's headquarters is in Allschwil Basel-Country, CH
  1. How many employees does Actelion have?

    Actelion has 2,421 employees
  2. What sector does Actelion operate in?

    Actelion is in Pharmaceuticals
  3. Who are Actelion's competitors?

    Actelion's top competitors are Gilead, Genentech, Amgen